OQS
PBH icon

Occudo Quantitative Strategies’s Prestige Consumer Healthcare PBH Stock Holding History

Occudo Quantitative Strategies’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,161
Closed -$1.14M – 914
2026
Q1 		$1.14M Buy
+20,161
New +$1.31M 0.06% 367
2023
Q3 		– Sell
-27,721
Closed -$1.65M – 1225
2023
Q2 		$1.65M Buy
+27,721
New +$1.66M 0.17% 177

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Occudo Quantitative Strategies's PBH Position: Q2 2026 in Review

Occudo Quantitative Strategies sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 20,161 shares — an estimated $1.14M sold.

Occudo Quantitative Strategies first reported a position in PBH in Q2 2023 and held it in 2 quarters. The position peaked at $1.65M in Q2 2023. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Occudo Quantitative Strategies reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 20,161 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.14M.
  • Occudo Quantitative Strategies first reported a position in Prestige Consumer Healthcare in Q2 2023 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Prestige Consumer Healthcare position peaked at $1.65M in Q2 2023.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.